Malnutrition outweighs the effect of the obesity paradox.


Journal

Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883

Informations de publication

Date de publication:
06 2022
Historique:
revised: 08 02 2022
received: 29 10 2021
accepted: 21 02 2022
pubmed: 31 3 2022
medline: 11 6 2022
entrez: 30 3 2022
Statut: ppublish

Résumé

High body mass index (BMI) is paradoxically associated with better outcome in patients with heart failure (HF). The effects of malnutrition on this phenomenon across the whole spectrum of HF have not yet been studied. In this observational study, patients were classified by guideline diagnostic criteria to one of three heart failure subtypes: reduced (HFrEF), mildy reduced (HFmrEF), and preserved ejection fraction (HFpEF). Data were retrieved from the Viennese-community healthcare provider network between 2010 and 2020. The relationship between BMI, nutritional status reflected by the prognostic nutritional index (PNI), and survival was assessed. Patients were classified by the presence (PNI < 45) or absence (PNI ≥ 45) of malnutrition. Of the 11 995 patients enrolled, 6916 (58%) were classified as HFpEF, 2809 (23%) HFmrEF, and 2270 HFrEF (19%). Median age was 70 years (IQR 61-77), and 67% of patients were men. During a median follow-up time of 44 months (IQR 19-76), 3718 (31%) of patients died. After adjustment for potential confounders, BMI per IQR increase was independently associated with better survival (adj. hazard ratio [HR]: 0.91 [CI 0.86-0.97], P = 0.005), this association remained significant after additional adjustment for HF type (adj. HR: 0.92 [CI 0.86-0.98], P = 0.011). PNI was available in 10 005 patients and lowest in HFrEF patients. PNI was independently associated with improved survival (adj. HR: 0.96 [CI 0.95-0.97], P < 0.001); additional adjustment for HF type yielded similar results (adj. HR: 0.96 [CI 0.96-0.97], P < 0.001). Although obese patients experienced a 30% risk reduction, malnutrition at least doubled the risk for death with 1.8- to 2.5-fold higher hazards for patients with poor nutritional status compared with normal weight well-nourished patients. The obesity paradox seems to be an inherent characteristic of HF regardless of phenotype and nutritional status. Yet malnutrition significantly changes trajectory of outcome with regard to BMI alone: obese patients with malnutrition have a considerably worse outcome compared with their well-nourished counterparts, outweighing protective effects of high BMI alone. In this context, routine recommendation towards weight loss in patients with obesity and HF should generally be made with caution and focus should be shifted on nutritional status.

Sections du résumé

BACKGROUND
High body mass index (BMI) is paradoxically associated with better outcome in patients with heart failure (HF). The effects of malnutrition on this phenomenon across the whole spectrum of HF have not yet been studied.
METHODS
In this observational study, patients were classified by guideline diagnostic criteria to one of three heart failure subtypes: reduced (HFrEF), mildy reduced (HFmrEF), and preserved ejection fraction (HFpEF). Data were retrieved from the Viennese-community healthcare provider network between 2010 and 2020. The relationship between BMI, nutritional status reflected by the prognostic nutritional index (PNI), and survival was assessed. Patients were classified by the presence (PNI < 45) or absence (PNI ≥ 45) of malnutrition.
RESULTS
Of the 11 995 patients enrolled, 6916 (58%) were classified as HFpEF, 2809 (23%) HFmrEF, and 2270 HFrEF (19%). Median age was 70 years (IQR 61-77), and 67% of patients were men. During a median follow-up time of 44 months (IQR 19-76), 3718 (31%) of patients died. After adjustment for potential confounders, BMI per IQR increase was independently associated with better survival (adj. hazard ratio [HR]: 0.91 [CI 0.86-0.97], P = 0.005), this association remained significant after additional adjustment for HF type (adj. HR: 0.92 [CI 0.86-0.98], P = 0.011). PNI was available in 10 005 patients and lowest in HFrEF patients. PNI was independently associated with improved survival (adj. HR: 0.96 [CI 0.95-0.97], P < 0.001); additional adjustment for HF type yielded similar results (adj. HR: 0.96 [CI 0.96-0.97], P < 0.001). Although obese patients experienced a 30% risk reduction, malnutrition at least doubled the risk for death with 1.8- to 2.5-fold higher hazards for patients with poor nutritional status compared with normal weight well-nourished patients.
CONCLUSIONS
The obesity paradox seems to be an inherent characteristic of HF regardless of phenotype and nutritional status. Yet malnutrition significantly changes trajectory of outcome with regard to BMI alone: obese patients with malnutrition have a considerably worse outcome compared with their well-nourished counterparts, outweighing protective effects of high BMI alone. In this context, routine recommendation towards weight loss in patients with obesity and HF should generally be made with caution and focus should be shifted on nutritional status.

Identifiants

pubmed: 35352504
doi: 10.1002/jcsm.12980
pmc: PMC9178364
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1477-1486

Subventions

Organisme : Austrian Science Fund
ID : KLI 700-B30

Informations de copyright

© 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Références

J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):1-5
pubmed: 21475699
Clin Pharmacol Ther. 2011 Jul;90(1):188-90
pubmed: 21654743
J Cardiol. 2013 Nov;62(5):307-13
pubmed: 23806549
Eur J Prev Cardiol. 2021 Aug 9;28(9):948-955
pubmed: 34402870
Int J Obes (Lond). 2017 Aug;41(8):1162-1163
pubmed: 28584251
Am J Clin Nutr. 2021 Mar 11;113(3):695-705
pubmed: 33236050
Int J Cardiol. 2017 Mar 1;230:108-114
pubmed: 28038805
BMJ. 2021 Jun 30;373:n1421
pubmed: 34193442
J Card Fail. 2011 Jun;17(6):451-8
pubmed: 21624732
N Engl J Med. 2002 Aug 1;347(5):305-13
pubmed: 12151467
Nutrition. 2000 Feb;16(2):131-40
pubmed: 10696638
Age Ageing. 1996 Mar;25(2):144-9
pubmed: 8670544
J Am Coll Cardiol. 2003 Oct 1;42(7):1218-23
pubmed: 14522484
Nutr Hosp. 2011 May-Jun;26(3):594-601
pubmed: 21892580
Lancet. 2000 Sep 9;356(9233):930-3
pubmed: 11036910
JACC Heart Fail. 2018 Jun;6(6):476-486
pubmed: 29753673
Circ Res. 2018 Jun 8;122(12):1642-1644
pubmed: 29880498
Int J Obes (Lond). 2014 Aug;38(8):1110-4
pubmed: 24173404
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2259-2261
pubmed: 34904399
J Am Heart Assoc. 2017 Jun 25;6(6):
pubmed: 28649089
Eur Heart J. 1999 May;20(9):683-93
pubmed: 10208789
Ann Surg Oncol. 2015 Dec;22(13):4138-48
pubmed: 25801356
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Heart Fail Rev. 2016 Sep;21(5):549-65
pubmed: 26920682
Int J Cardiol. 2015 Feb 15;181:120-6
pubmed: 25497534
Sci Rep. 2017 Jun 12;7(1):3285
pubmed: 28607442
J Am Coll Cardiol. 2009 May 26;53(21):1925-32
pubmed: 19460605
Mayo Clin Proc. 2010 Jul;85(7):609-17
pubmed: 20592169
Mayo Clin Proc. 2016 Jul;91(7):858-66
pubmed: 27289411
J Am Soc Echocardiogr. 2019 Jan;32(1):1-64
pubmed: 30282592
JPEN J Parenter Enteral Nutr. 2016 May;40(4):475-86
pubmed: 25634161

Auteurs

Suriya Prausmüller (S)

Division of Cardiology, Department of Internal Medicine, II, Medical University of Vienna, Vienna, Austria.

Gregor Heitzinger (G)

Division of Cardiology, Department of Internal Medicine, II, Medical University of Vienna, Vienna, Austria.

Noemi Pavo (N)

Division of Cardiology, Department of Internal Medicine, II, Medical University of Vienna, Vienna, Austria.

Georg Spinka (G)

Division of Cardiology, Department of Internal Medicine, II, Medical University of Vienna, Vienna, Austria.

Georg Goliasch (G)

Division of Cardiology, Department of Internal Medicine, II, Medical University of Vienna, Vienna, Austria.

Henrike Arfsten (H)

Division of Cardiology, Department of Internal Medicine, II, Medical University of Vienna, Vienna, Austria.

Cornelia Gabler (C)

IT Systems and Communications, Medical University of Vienna, Vienna, Austria.

Guido Strunk (G)

Complexity Research, Vienna, Austria.

Christian Hengstenberg (C)

Division of Cardiology, Department of Internal Medicine, II, Medical University of Vienna, Vienna, Austria.

Martin Hülsmann (M)

Division of Cardiology, Department of Internal Medicine, II, Medical University of Vienna, Vienna, Austria.

Philipp E Bartko (PE)

Division of Cardiology, Department of Internal Medicine, II, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH